Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Safflower (Carthamus tinctorius) extract helps hair grow and could be used in hair products.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Using steroids can increase the risk of heart problems.

Higher BMI links to worse hair loss in Taiwanese men.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Female hair loss linked to metabolic syndrome, not in males.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.